However, this potential adaptive mechanism may come at a price: downregulation of KCC2 may also play a role in several pathophysiological conditions, such as epilepsy, neuropathic pain, spasticity, and neuropsychiatric disorders (schizophrenia and autism spectrum disorder)21,26,53,56. The gene discussed is SLC12A5; the disease is epilepsy.